A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adults.

MLA

Durier, Christine, et al. “A 5-Year Neutralizing Immune Response to Yellow Fever Vaccine in HIV-Infected and HIV-Uninfected Adults.” AIDS (02699370), vol. 36, no. 2, Feb. 2022, pp. 319–21. EBSCOhost, https://doi.org/10.1097/QAD.0000000000003114.

APA

Durier, C., Mercier-Delarue, S., Verdière, N. C. D., Meiffrédy, V., Matheron, S., Samri, A., Resch, M., Marchand, L., Autran, B., Launay, O., Simon, F., & ANRS NOVAA EP46 study group. (2022). A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adults. AIDS (02699370), 36(2), 319–321. https://doi.org/10.1097/QAD.0000000000003114

Chicago

Durier, Christine, Séverine Mercier-Delarue, Nathalie Colin De Verdière, Vincent Meiffrédy, Sophie Matheron, Assia Samri, Martine Resch, et al. 2022. “A 5-Year Neutralizing Immune Response to Yellow Fever Vaccine in HIV-Infected and HIV-Uninfected Adults.” AIDS (02699370) 36 (2): 319–21. doi:10.1097/QAD.0000000000003114.